Associated Papers
BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib.
Karachaliou N et al.
Jto Clinical and Research Reports, 2021
34589994 (PubMed )
Supplement: mmc1.pdf
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.
Galvani E et al.
Oncotarget, 2015
26015408 (PubMed )
Supplement: oncotarget-06-42717-s001.pdf
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.
Rosell R et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2011
Select a paper to view details